Show simple item record

dc.contributor.authorHackett, Geoffrey
dc.contributor.authorMann, Amar
dc.contributor.authorHaider, Ahmad
dc.contributor.authorHaider, Karim S
dc.contributor.authorDesnerck, Pieter
dc.contributor.authorKönig, Carola S
dc.contributor.authorStrange, Richard C
dc.contributor.authorRamachandran, Sudarshan
dc.date.accessioned2024-12-13T12:08:25Z
dc.date.available2024-12-13T12:08:25Z
dc.date.issued2024-02-14
dc.identifier.citationHackett G, Mann A, Haider A, Haider KS, Desnerck P, König CS, Strange RC, Ramachandran S. Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men. World J Mens Health. 2024 Oct;42(4):749-761. doi: 10.5534/wjmh.230239. Epub 2024 Feb 14.en_US
dc.identifier.issn2287-4208
dc.identifier.eissn2287-4690
dc.identifier.doi10.5534/wjmh.230239
dc.identifier.pmid38449452
dc.identifier.urihttp://hdl.handle.net/20.500.14200/6714
dc.description.abstractPurpose: While testosterone therapy can improve the various pathologies associated with adult-onset testosterone deficiency (TD), Summary of Product Characteristics (SPC) of five testosterone preparations caution that treatment may be associated with hypertension. This paper evaluates the impact of testosterone undecanoate (TU) on blood pressure (BP) in men with adult-onset TD. Materials and methods: Of 737 men with adult-onset TD in an on-going, observational, prospective, cumulative registry, we studied changes in BP using non-parametric sign-rank tests at final assessment and fixed time points. We used multiple regression analysis to establish factors (baseline BP, age, change/baseline waist circumference [WC] and hematocrit [HCT] and follow-up) potentially associated with BP change in men on TU. Results: TU was associated with significant reductions in systolic, diastolic BP and pulse pressure, regardless of antihypertensive therapy (at baseline or during follow-up), larger reductions were seen with concurrent antihypertensive therapy. In men never on antihypertensive agents, median changes (interquartile range [IQR]) in systolic BP, diastolic BP and pulse pressure were -12.5 (-19.0, -8.0), -8.0 (-14.0, -3.0), and -6.0 (-10.0, -1.0) mmHg, respectively at final assessment, with only baseline BP values inversely associated with these changes (HCT and WC were not significantly associated). In men not on TU, systolic BP, diastolic BP, and pulse pressure significantly increased. In the TU treated men only 1 of the 152 men (not on antihypertensive agents at baseline) were started on antihypertensives during follow-up. In contrast 33 of the 202 men on antihypertensives (at baseline or follow-up) had the antihypertensive agent discontinued by the end of the follow-up. Conclusions: TU was associated with lowering of BP during follow-up irrespective of antihypertensive therapy, with greater reductions in men with higher baseline BP. In the context of SPC warnings, our long-term data provide reassurance on the effect of TU on BP.en_US
dc.language.isoenen_US
dc.publisherKorean Society for Sexual Medicine and Andrologyen_US
dc.relation.urlhttps://wjmh.org/en_US
dc.rightsCopyright © 2024 Korean Society for Sexual Medicine and Andrology.
dc.subjectClinical pathologyen_US
dc.subjectEndocrinologyen_US
dc.titleTestosterone replacement therapy: effects on blood pressure in hypogonadal menen_US
dc.typeArticleen_US
dc.source.journaltitleThe World journal of Men's Healthen_US
dc.source.volume42
dc.source.issue4
dc.source.beginpage749
dc.source.endpage761
dc.source.countryUnited Kingdom
dc.source.countryKorea (South)
rioxxterms.versionNAen_US
dc.contributor.trustauthorMann, Amar
dc.contributor.trustauthorRamachandran, Sudarshan
dc.contributor.departmentRespiratoryen_US
dc.contributor.departmentPathologyen_US
dc.contributor.roleMedical and Dentalen_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record